•  
  •  
 

Abstract

Introduction. Retention in care is important to the successful of HIV treatment. This study is aimed to analyze factors associated with retention in care one year after delivery in patients undergoing PMTCT at HIV integrated clinic of RSCM. Methods. A retrospective cohort study was conducted among post-partum HIV patients who were given ARV therapy for PMTCT at HIV intergrated clinic of Cipto Mangunkusumo Hospital from January 2004 to May 2014. Evaluation of one year retention in care after PMTCT was performed by observing medical records of the patient. The collected data were factors associated with one year after delivery retention in care including age of patients, level of initial CD4, ARV toxicity, injecting drug user, duration of ARV before delivery, having child with positive HIV status, having spouse with positive HIV status, distance from the residence to the hospital, and indication of ARV. Bivariate analysis was performed by using Chi Square and Mann Whitney test and multivariate anaysis was performed by using logistic regression to assess factors associated with retention in car after PMTCT program. Results. 253 subjects met the inclusion criteria. In One year after delivery, the retention in care rate was 55,3%. Multivariate analysis found that factors significantly associated with one year retention in care were indication of ARV initiation for therapy (OR =3,812 [95% CI: 1,825-7,966]), non-IDU patients (OR=3,055 [95% CI: 1,382-6,752]), duration of ARV before delivery for more than 6 months (OR = 2,657 [95% CI: 1,328-5,316]), and level of initial CD4 less than 200/mm3 (OR = 2,033 [95% CI: 1,061-3,894]). Conclusions. Factors significantly associated with one year after delivery retention in care are indication of ARV for therapy, duration of ARV before delivery, non-IDU patients, and level of initial CD4 less than 200/mm3 . and Mann Whitney test and multivariate anaysis was performed by using logistic regression to assess factors associated with retention in car after PMTCT program. Results. 253 subjects met the inclusion criteria. In One year after delivery, the retention in care rate was 55,3%. Multivariate analysis found that factors significantly associated with one year retention in care were indication of ARV initiation for therapy (OR =3,812 [95% CI: 1,825-7,966]), non-IDU patients (OR=3,055 [95% CI: 1,382-6,752]), duration of ARV before delivery for more than 6 months (OR = 2,657 [95% CI: 1,328-5,316]), and level of initial CD4 less than 200/mm3 (OR = 2,033 [95% CI: 1,061-3,894]). Conclusions. Factors significantly associated with one year after delivery retention in care are indication of ARV for therapy, duration of ARV before delivery, non-IDU patients, and level of initial CD4 less than 200/mm3 .

References

1. Kementerian Kesehatan Republik Indonesia. Pedoman Nasional Pencegahan Penularan HIV dari Ibu ke Anak (PPIA). Jakarta: Kementerian Kesehatan RI; 2012. 2. WHO. Antiretroviral drugs for treating pregnant woman and preventing HIV infection in infant: recommendation for a public health approach. Geneva: WHO; 2010 [disitasi 2 September 2016]. Diunduh dari: http://apps.who.int/iris/ bitstream/10665/75236/1/9789241599818_eng.pdf. 3. UNAIDS. Report. Global report. Geneva: UNAIDS; 2012 [disitasi 5 September 2016]. Diunduh dari: http://files.unaids.org/en/ media/unaids/contentassets/documents/epidemiology/2012/ gr2012/20121120_UNAIDS_Global_Report_2012_with_annexes_ en.pdf. 4. Kementerian Kesehatan Republik Indonesia. Laporan Triwulan Desember 2013. Jakarta: Kementerian Kesehatan RI; 2013. 5. USAID. Adult adherence to treatment and retention in care. Washington: USAID; 2010 [disitasi 1 Oktober 2016]. Diunduh dari: http://pdf.usaid.gov/pdf_docs/PNADX307.pdf. 6. Geng EH, Nash D, Kambugu A, Zhang Y, Braitstein P, Christopouluos KA, et al. Retention in care among HIV-infected patients in resourcelimited settings: emerging insights and new directions. Curr HIV/ AIDS Rep. 2010;7(4):234–44. 7. Mellins CA, Chu C, Malee K, Allison S, Smith R, Harris L, et al. Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women. AIDS Care. 2008;20(8):958–68. 8. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in Sub-Saharan Africa: a systematic review. PLoS Med. 2007;4(10):e298. 9. Lessels RJ, Mutevezdzi PC, Cooke G, Newell ML. Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 2011;56(3):e79–86. 10. Ekouvi DK, Inwoley A, Gold BT, Danel C, Becquet R, Viho I, et al. Variation of CD4 cell count and percentage during pregnancy and after delivery: implications for HAART initiation in resource-limited settings. AIDS Res Hum Retrovir. 2007;23:1469-974. 11. Kementerian Kesehatan Republik Indonesia. Laporan Perkembangan HIV-AIDS Triwulan IV Tahun 2014. Jakarta: Kementerian Kesehatan RI; 2015. 12. Nachega JB, Knowlton AR, Deluca A, Schoeman JA, Watkinson L, Efron A, et al. Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative study. J Acqui Immune Defic Syndr. 2006;43(1):S127–33. 13. Santoso RFH, Ariyanti F, Azizi MS, Yunihastuti E. Desire to get married and have children in people living with HIV infection (PLHIV) on antiretroviral therapy. Proceedings of the 7th Jakarta Allergy and Clinical Immunology Network (JACIN) Meeting, 2012 May 25-27; Jakarta: Indonesian Society for Allergy-Immunology (Peralmuni) and CME-CPD Unit, Department of Internal Medicine, Faculty of Medicine, University of Indonesia; 2012. p.98. 14. Kementerian Kesehatan Republik Indonesia. Laporan Bulan Perawatan HIV 2005-2012. Jakarta: Kementerian Kesehatan RI; 2013. 15. World Health Organization. Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and care for key populations. Geneva: WHO; 2014. 16. Clouse K, Pettifor AE, Maskew M, Bassett J, Rie AV, Behets F, et al. Patient retention from HIV diagnosis through one year on antiretroviral therapy at a primary health care clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2013;62(2):e39-46. 17. Thompson AM, Mugavero MJ, Amico KR, Cargill VA, Chang LW, Gross R, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidencebased recommendations from an International Association of Physicians in AIDS Care Panel. Ann Intern Med. 2012;156(11):817- 33. 18. Giordano TP, Harman C, Gifford AL, Backus LI, Morgan RO. Predictors of retention in HIV care among a national cohort of US veterans. HIV Clin Trials. 2009;10(5):299–305. 19. Carrieri MP, Chesney MA, Spire B, Loundou A, Sobel A, Lepeu G, Moatti JP, et al. Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users. Int J Behav Med. 2003;10(1):1-14. 20. Boyles TH, Wilkinson LS, Leisegang R, Maartens G. Factors influencing retention in care after starting antiretroviral therapy in a rural South African programme. Plos One. 2011;6:e19201.

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.